The stock has witnessed two upward estimate revisions in the past 30 days. The Zacks Consensus Estimate has also moved up over the same time frame, suggesting that more solid trading could be ahead for IntelliPharmaCeutics International. So make sure to keep an eye on this stock going forward to see if the latest jump can turn into more strength down the road.
IntelliPharmaCeutics International sports a Zacks Rank #1 (Strong Buy), while its Earnings ESP is 0.00%.
Investors interested in the med-drugs industry may also consider Anacor Pharmaceuticals, Inc. (ANAC) with the same rank as IntelliPharmaCeutics International.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment